# EDGAR Filing Document

**Accession Number:** 0001441755
**File Stem:** 0001062993-23-006688
**Filing Date:** 2023-3
**Character Count:** 11928
**Document Hash:** 20595a08473770e6268377265398d70f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-006688.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001062993-23-006688

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230310

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** White Matthew J
- **CENTRAL INDEX KEY:** 0001441755

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38730
- **FILM NUMBER:** 23726466

**MAIL ADDRESS:**
- **STREET 1:** C/O PRAXAIR, INC.
- **STREET 2:** 39 OLD RIDGEBURY ROAD
- **CITY:** DANBURY
- **STATE:** CT
- **ZIP:** 12533
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LINDE PLC
- **CENTRAL INDEX KEY:** 0001707925
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INORGANIC CHEMICALS [2810]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT
- **BUSINESS PHONE:** 00441483242200

**MAIL ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170622

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRAXAIR
- **DATE OF NAME CHANGE:** 20170614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170530

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>White Matthew J<br><sub>(Last) (First) (Middle)</sub><br>C/O LINDE PLC<br>43 CHURCH STREET WEST<br><sub>(Street)</sub><br>WOKING, SURREY, X0 GU21 6HT<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-10 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LINDE PLC [ LIN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | M |  | 3590<sup>(2)</sup> | A | $0 | 50391 | D |  |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | F |  | 1664<sup>(3)</sup> | D | $345.92 | 48727 | D |  |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | M |  | 10770<sup>(4)</sup> | A | $0 | 59497 | D |  |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | F |  | 4991<sup>(3)</sup> | D | $345.92 | 54506 | D |  |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | M |  | 5830<sup>(5)</sup> | A | $0 | 60336 | D |  |
| Ordinary Shares<sup>(1)</sup> | 2023-03-10 |  | F |  | 2702<sup>(3)</sup> | D | $345.92 | 57634 | D |  |
| Ordinary Shares<sup>(1)</sup> |  |  |  |  |  |  |  | 2960.4510 | I | 401(k) |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance Share Units<sup>(1)</sup> | 0<sup>(4)</sup> | 2023-03-10 |  | A |  | 10770 |  | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 10770 | $0 | 10770 | D |  |
| Performance Share Units<sup>(1)</sup> | 0<sup>(4)</sup> | 2023-03-10 |  | M |  |  | 10770 | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 10770 | $0 | 0 | D |  |
| Performance Share Units<sup>(1)</sup> | 0<sup>(5)</sup> | 2023-03-10 |  | A |  | 5830 |  | <sup>(5)</sup> | <sup>(5)</sup> | Ordinary Shares | 5830 | $0 | 5830 | D |  |
| Performance Share Units<sup>(1)</sup> | 0<sup>(5)</sup> | 2023-03-10 |  | M |  |  | 5830 | <sup>(5)</sup> | <sup>(5)</sup> | Ordinary Shares | 5830 | $0 | 0 | D |  |
| Restricted Stock Units<sup>(1)</sup> | <sup>(6)</sup> |  |  |  |  |  |  | <sup>(6)</sup> | <sup>(6)</sup> | Ordinary Shares | 2870 |  | 2870 | D |  |
| Restricted Stock Units<sup>(1)</sup> | <sup>(7)</sup> |  |  |  |  |  |  | <sup>(7)</sup> | <sup>(7)</sup> | Ordinary Shares | 2600 |  | 2600 | D |  |
| Restricted Stock Units<sup>(1)</sup> | <sup>(8)</sup> |  |  |  |  |  |  | <sup>(8)</sup> | <sup>(8)</sup> | Ordinary Shares | 3260 |  | 3260 | D |  |
| Restricted Stock Units<sup>(1)</sup> | 0<sup>(2)</sup> | 2023-03-10 |  | M |  |  | 3590 | <sup>(2)</sup> | <sup>(2)</sup> | Ordinary Shares | 3590 | $0 | 0 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $354.14 |  |  |  |  |  |  | 2024-03-07<sup>(9)</sup> | 2033-03-07 | Ordinary Shares | 18970 |  | 18970 | D |  |
| Stock Options (right to buy)<sup>(1)</sup> | $270.99 |  |  |  |  |  |  | 2023-03-07<sup>(10)</sup> | 2032-03-07 | Ordinary Shares | 22535 |  | 22535 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $253.68 |  |  |  |  |  |  | 2022-03-08<sup>(11)</sup> | 2031-03-08 | Ordinary Shares | 34320 |  | 34320 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $173.13 |  |  |  |  |  |  | 2021-03-09<sup>(12)</sup> | 2030-03-09 | Ordinary Shares | 43695 |  | 43695 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $176.63 |  |  |  |  |  |  | 2020-03-20<sup>(13)</sup> | 2029-03-20 | Ordinary Shares | 47020 |  | 47020 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $128.38 |  |  |  |  |  |  | 2016-02-24<sup>(13)</sup> | 2025-02-24 | Ordinary Shares | 40865 |  | 40865 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $102.22 |  |  |  |  |  |  | 2017-02-23<sup>(13)</sup> | 2026-02-23 | Ordinary Shares | 85205 |  | 85205 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $118.71 |  |  |  |  |  |  | 2018-02-28<sup>(13)</sup> | 2027-02-28 | Ordinary Shares | 72795 |  | 72795 | D |  |
| Stock Option (right to buy)<sup>(1)</sup> | $154.00 |  |  |  |  |  |  | 2019-02-27<sup>(13)</sup> | 2028-02-27 | Ordinary Shares | 64665 |  | 64665 | D |  |
| Deferred Stock Units<sup>(1)</sup> | <sup>(14)</sup> |  |  |  |  |  |  | <sup>(15)</sup> | <sup>(15)</sup> | Ordinary Shares | 1273.319 |  | 1273.319 | D |  |

---

### Footnotes:

(1) On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

(2) Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020.

(3) Shares of common stock withheld from the payout to cover tax withholdings.

(4) The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital  ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

(5) The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

(6) Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

(7) Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

(8) Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

(9) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

(10) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

(11) This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

(12) This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

(13) This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

(14) Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

(15) Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan").  The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

**Signature:** Anthony M. Pepper, Attorney-in-Fact  
**Date:** 2023-03-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**